LifeWatch AG

EANS-Adhoc: LifeWatch AG
hires top Healthcare Executive to lead Sales

@@start.t1@@--------------------------------------------------------------------------------   ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide   distribution. The issuer is solely responsible for the content of this   announcement. --------------------------------------------------------------------------------@@end@@

Company Information

16.09.2010

Stephen J. Zielinski appointed Senior Vice President of Sales of LifeWatch Corp.

Neuhausen am Rheinfall/ Switzerland - LifeWatch AG (SIX Swiss Exchange: LIFE) announced today the appointment of Stephen J. Zielinski as Senior Vice President of Sales of LifeWatch Corp., effective September 20, 2010. Brent Atwood, former Chief Sales Officer of LifeWatch Services, Inc., will pursue opportunities outside the company.

Mr. Stephen Zielinski brings to LifeWatch over 20 years of sales and sales management experience with leading firms in the cardiology and medical device industries. Mr. Zielinski has specialized in  building and growing sales organizations. His past experience includes VP of Sales for Angiotech´s Interventional & Surgical products, where he managed a dozen regional managers and 120 sales representatives. Mr. Zielinski spent thirteen years with Boston Scientific (Minnesota, USA) where he was most recently the Director of Sales for the Peripheral & Vascular Division and the Cardiovascular Division. In addition, Mr Zielinski led the new product launch of Boston Scientific´s highly successful Taxus stent line. During his tenure at Boston Scientific, Mr. Zielinski also led the development and operation of a sales training division of 38 specialists and trainers and was responsible for the integration of sales force automation tools to over 300 sales representatives.  Mr. Zielinski previously held senior sales management positions at various other firms such as CoAxia, Inc. (Minnesota, USA), an early stage company focusing on   products for ischemic stroke. Mr. Zielinski holds a Bachelor of Science degree in Business Management from Purdue University.

"We are very excited that Steve is joining LifeWatch as we expand our advanced wireless healthcare services to other remote patient monitoring markets," stated Brent Cohen, CEO of LifeWatch AG, the parent company of LifeWatch Corp. "His deep, cardiac-related experience and proven management skills will be invaluable assets as we continue to expand our presence in the cardiac monitoring market and as we enter new service industries such as home sleep testing."

About LifeWatch AG LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed  on  SIX  Swiss Exchange (LIFE), Switzerland, is the leading healthcare technology and  solution company, specializing in  advanced  telemedicine  systems  and  wireless  remote patient monitoring services. LifeWatch services cater  to  individuals,   ranging from high-risk  and  chronically  ill  patients,  to   consumers  of  health  and wellness  products.  LifeWatch  has   subsidiaries  in  the  United  States,  the Netherlands, Japan, the United Kingdom, Switzerland and Israel. LifeWatch AG  is the parent company of  LifeWatch  Services  Inc.,  a  leading  US-based  cardiac monitoring service provider. LifeWatch has also introduced  a  new   program  for Home Sleep Testing of Obstructive Sleep Apnea (OSA)   patients  under  the  brand name NiteWatch. For additional information, please visit www.lifewatch.com.

Sign-up for customized E-mail alerts and documentation requests is available  at http://production.investis.com/lifewatch/alert-service/

This press release includes forward-looking  statements.  All   statements  other than statements of historical facts contained in this press  release,  including statements regarding  future  results of  operations  and  financial  position, business strategy and plans and objectives for future operations,  are  forward- looking statements. The words "believe," "may," "will," "estimate,"   "continue," "anticipate,"  "intend,"  "expect"  and  similar   expressions  are  intended  to identify forward-looking statements.   LifeWatch  AG  has  based  these  forward- looking statements largely on current expectations and projections about  future events  and   financial  trends  that  it  believes  may  affect  the    financial condition, results of operations, business strategy, short term  and long  term business operations and objectives, and financial needs.   These  forward-looking statements are subject to a number of risks, uncertainties and  assumptions.  In light of these risks, uncertainties and assumptions, the forward-looking  events and circumstances described may  not  occur  and  actual  results  could differ materially and adversely from those  anticipated  or  implied in  the  forward- looking statements. All  forward-looking   statements  are  based  only  on  data available to LifeWatch AG at the time  of  the  issue  of  this  press  release. LifeWatch AG does not undertake any obligation  to  update  any  forward-looking statements contained in this press release  as  a  result  of  new   information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN  THE  UNITED  STATES  OF   AMERICA  AND SHOULD NOT BE DISTRIBUTED TO  UNITED  STATES  PERSONS   OR  PUBLICATIONS  WITH  A GENERAL  CIRCULATION  IN  THE  UNITED   STATES.    THIS  PRESS  RELEASE  DOES  NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH AG OR  ANY  OF  ITS  SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE  ANY SECURITIES OF LIFEWATCH  AG  OR  ITS  SUBSIDIARIES  IN  THE  UNITED   STATES.  IN ADDITION, THE SECURITIES OF LIFEWATCH AG AND  ITS   SUBSIDIARIES  HAVE  NOT  BEEN REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE OFFERED,  SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO  U.S.  PERSONS  ABSENT  REGISTRATION UNDER OR AN APPLICABLE EXEMPTION  FROM  THE  REGISTRATION  REQUIREMENTS  OF  THE UNITED STATES SECURITIES LAWS.  ANY PUBLIC OFFERING OF SECURITIES TO BE MADE  IN THE UNITED STATES WILL BE MADE BY MEANS OF A PROSPECTUS   THAT  MAY  BE  OBTAINED FROM LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN  DETAILED INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL  STATEMENTS OF THE ISSUER.

@@start.t2@@end of announcement                                                 euro adhoc
--------------------------------------------------------------------------------@@end@@

ots Originaltext: LifeWatch AG
Im Internet recherchierbar: http://www.presseportal.ch

Further inquiry note:
For further information please contact:
Woo Kim, Senior Vice President of Strategy and Business Development, LifeWatch
Tel +1 847 813 4299 | Fax +1 847 813 24 48 | E-mail wkim@lifewatch.com

Sensus Investor & Public Relations, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | E-mail lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN:      CH0012815459
WKN:        1281545
Index:    SPI, SPIEX
Börsen:  Frankfurt / Open Market / XETRA
              Berlin / free trade
              SIX Swiss Exchange / Main Standard



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: